Bernstein Upgrades Edwards Lifesciences to Market Perform From Underperform, Adjusts Price Target to $71 From $65
Bernstein Upgrades Edwards Lifesciences to Market Perform From Underperform, Adjusts Price Target to $71 From $65
伯恩斯坦将爱德华生命科学评级从表现不佳升级至市场表现，将目标股价从65美元调整至71美元
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间